Literature DB >> 7513907

Prooxidant and antioxidant properties of iron-hydroquinone and iron-1,2,4-benzenetriol complex. Implications for benzene toxicity.

V Singh1, S Ahmad, G S Rao.   

Abstract

Bleomycin-dependent degradation of DNA in bone marrow cells was studied in vitro in the presence of iron or iron polyphenol chelates which are formed during biotransformation of benzene. Iron polyphenol chelates markedly enhanced bleomycin-dependent DNA degradation in comparison to iron alone. About 1.5 and 2.5-fold increase was observed in the presence of iron hydroquinone (HQ) chelate and iron 1,2,4-benzenetriol (BT) chelate, respectively. Endogenous iron chelators such as glutamate, citrate, aspartate, glycine, cysteine, dithiothreitol, AMP, ADP and ATP did not enhance iron-catalysed bleomycin-dependent degradation of DNA. By bleomycin assay, the recovery of iron polyphenol chelate added externally to bone marrow lysate was complete. However, the presence of iron polyphenol chelate resulted in less thiobarbituric acid reactive products from glutamate or brain homogenate than with iron alone. The optical spectra of BT were modified in the presence of ferrous sulphate, revealing a new absorption peak at 259 nm indicating complexation with iron. Thus, the iron polyphenol chelate, on one hand, is a more potent DNA cleaving agent in the presence of bleomycin, and on the other hand, it is a less effective free radical generator as compared to iron alone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513907     DOI: 10.1016/0300-483x(94)90130-9

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  5 in total

1.  Effect of iron reduction by enolic hydroxyl groups on the stability of scorodite in hydrometallurgical industries and arsenic mobilization.

Authors:  Zidan Yuan; Shaofeng Wang; Xu Ma; Xin Wang; Guoqing Zhang; Yongfeng Jia; Wei Zheng
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-26       Impact factor: 4.223

2.  Genome-wide functional profiling reveals genes required for tolerance to benzene metabolites in yeast.

Authors:  Matthew North; Vickram J Tandon; Reuben Thomas; Alex Loguinov; Inna Gerlovina; Alan E Hubbard; Luoping Zhang; Martyn T Smith; Chris D Vulpe
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

3.  Phase II metabolism of benzene.

Authors:  D Schrenk; A Orzechowski; L R Schwarz; R Snyder; B Burchell; M Ingelman-Sundberg; K W Bock
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

4.  Cytochromes P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity.

Authors:  I Gut; V Nedelcheva; P Soucek; P Stopka; B Tichavská
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

Review 5.  Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview.

Authors:  Divya Singh; William C Cho; Ghanshyam Upadhyay
Journal:  Front Physiol       Date:  2016-01-26       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.